Eczema is a common skin condition, which can have a substantial impact on the sufferer’s quality of life. One of the possible treatments are the class of drugs called antihistamines and the relevant research was investigated in a Cochrane Review in February 2013. Christian Apfelbacher from the University of Regensburg in Germany led the review.